Tech Company Financing Transactions

Afferent Funding Round

Afferent, based in Providence, secured $4 million from New Science Ventures, Pharos Capital Group and Point Judith Capital Partners.

Transaction Overview

Company Information

Company Status

Out of Business

Industry

Medical Devices & Instruments

Mailing Address

275 Westminster St. 500
Providence, RI 02903
USA

Phone

(401) 453-9933

Website

www.afferentcorp.com

Email Address

[email protected]

Overview

Afferent Corporation is pioneering the development of a new class of Medical Devices & Instruments to treat chronic neurological dysfunction. Its lead technology enhances the function of mechanoreceptor cells involved in sensory perception as a means of restoring brain function following stroke, addressing complications resulting from diabetic neuropathy, and improving elderly balance.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

David Hable

        

Chief Technical Officer

Jason Harry

        

VP - Manufacturing

Scott Kellogg

        

VP - R & D

James Niemi

        

Browse more venture capital transactions:

Prev: 10/26/2004: Vette venture capital transaction
Next: 10/27/2004: Netblue venture capital transaction

Share this article

About Our Venture Capital Transactions Database

We do our best to report on funding rounds that are announced publicly. VC transactions reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary